Jaguar Health Inc.
JAGX | NASDAQ
$0.87
-$0.75 (-46.30%)
At close: Nov 2, 2026, 3:59 PM ET
$0.83
-$0.04 (-4.02%)
After-hours:
Nov 2, 2026, 6:53 PM ET
Market Data
Market Cap $2.03M
Enterprise Value $13.82M
Beta -0.06
Average Volume 1.42M
Shares Outstanding (Diluted) 53.94K
Shares Change YoY 2690.73%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US47010C8543
Price Performance
Price Change 1M -76.2%
Price Change 3M -94.2%
Price Change 6M -98.2%
Price Change YTD -99.8%
Price Change 1Y -99.9%
Price Change 3Y -100.0%
Price Change 5Y -100.0%
1M CAGR (ann.) -40.2%
1Y CAGR (ann.) -99.8%
5Y CAGR (ann.) -96.6%
All-Time CAGR -91.2%
Valuation
PE Ratio -0.00
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio 0.14
Forward PS 0.90
PB Ratio 0.57
P/FCF Ratio -0.56
P/Adj. FCF Ratio -0.66
P/OCF Ratio -0.01
EV/Sales 0.50
EV/EBIT -0.33
EV/EBITDA -0.34
EV/FCF -2.04
Earnings Yield -338407.4%
FCF Yield -179.7%
Adj. FCF Yield -151.4%
Financial Health
Net Debt $8.97M
Total Debt $16.65M
Cash & Short-Term Investments $6.59M
Total Assets $34.19M
Current Ratio 0.69
Quick Ratio 0.40
Debt / Equity Ratio 2.52
Debt / EBITDA -0.42
Debt / FCF -2.46
OCF / Debt -0.40
Interest Coverage -28.98
Altman Z-Score -19.98
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 82.3%
Operating Profit Margin -90.2%
EBITDA Margin -143.7%
Net Profit Margin -131.8%
FCF Margin -24.3%
Adj. FCF Margin -20.5%
SBC / Revenue -3.8%
SBC Impact (per share) -15.7%
Returns
Return on Assets -107.2%
Return on Equity 762.5%
Return on Invested Capital -109.8%
Return on Capital Employed -284.7%
Return on Tangible Assets -191.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 36.0%
Revenue CAGR 5Y 31.9%
Revenue CAGR 10Y 64.2%
EPS CAGR 3Y 136.3%
EPS CAGR 5Y 91.3%
EPS CAGR 10Y 37.9%
FCF CAGR 3Y 53.3%
FCF CAGR 5Y 25.3%
FCF CAGR 10Y -3.9%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$444.29
EPS Growth Est (next Q) 20113.6%
Revenue Est (next Q) $4.85M
Revenue Growth Est (next Q) 57.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3.21
Price Target Upside 98.1%
Cash Flow
Operating Cash Flow $-6.74M
Free Cash Flow $-6.76M
Adj. Free Cash Flow $-5.7M
FCF Per Share -$125.40
OCF Per Share -$124.93
OCF/S Ratio -24.2%
Income Statement
Revenue $27.82M
Gross Profit $22.89M
Operating Income $-25.1M
EBITDA $-40.09M
Net Income $-36.65M
EPS (Diluted) -$5,482.20
Revenue / Employee $591.81K
Profit / Employee $-779.74K
Employees 47
Add to Watchlist
Select watchlists to add or remove JAGX